Seeking Broad Intervention In India, Eli Lilly Goes To Roots To Check Non-communicable Diseases
This article was originally published in The Pink Sheet Daily
The Public Health Foundation of India, Project HOPE and Population Services International will be working with the company to focus on diabetes and, over time, cancer
You may also be interested in...
MUMBAI - Alarmed by the rapid increase in the number of non-communicable diseases, India's ministry of health and family welfare announced that the recently unveiled National Program for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke will be extended to the entire country over the next five years
MUMBAI - As Pfizer Inc. warms up for an entry into the rapidly growing Indian insulin market, Eli Lilly & Co., which is already established in the Indian market, is looking to strengthen its franchise via a strategic collaboration with Lupin Ltd. - an Indian company making significant strides in the anti-diabetes, cardiology, nephrology and respiratory segments
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.